---
figid: PMC4846185__kcbt-16-10-1071737-g007
figlink: /pmc/articles/PMC4846185/figure/f0007/
number: F7
caption: The role of ARF1 in mediating gefitinib sensitivity in breast cancer cells.
  (A) Upon treatment with the EGFRTKi, gefitinib, ARF1 is recruited to the RTK, AXL,
  leading to the activation of this GTPase. Activated ARF1 promotes signals through
  the survival pathways, ERK1/2, Src and AKT. Furthermore, ARF1 attenuates gefitinib-induced
  apoptotic signals through p38MAPK pathway and JNK activation. Additionally, the
  actions of ARF1 on the p38MAPK mediate the internalization and degradation of the
  EGFR. Altogether, ARF1 mediates gefitinib sensitivity in breast cancer cells by
  promoting cell survival and EGFR stability.
pmcid: PMC4846185
papertitle: The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of
  triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
reftext: Eric Haines, et al. Cancer Biol Ther. 2015 Oct;16(10):1535-1547.
pmc_ranked_result_index: '76097'
pathway_score: 0.9561754
filename: kcbt-16-10-1071737-g007.jpg
figtitle: ARF1 in mediating gefitinib sensitivity in breast cancer cells
year: '2015'
organisms: Homo sapiens
ndex: 4da96bab-debf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4846185__kcbt-16-10-1071737-g007.html
  '@type': Dataset
  description: The role of ARF1 in mediating gefitinib sensitivity in breast cancer
    cells. (A) Upon treatment with the EGFRTKi, gefitinib, ARF1 is recruited to the
    RTK, AXL, leading to the activation of this GTPase. Activated ARF1 promotes signals
    through the survival pathways, ERK1/2, Src and AKT. Furthermore, ARF1 attenuates
    gefitinib-induced apoptotic signals through p38MAPK pathway and JNK activation.
    Additionally, the actions of ARF1 on the p38MAPK mediate the internalization and
    degradation of the EGFR. Altogether, ARF1 mediates gefitinib sensitivity in breast
    cancer cells by promoting cell survival and EGFR stability.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - MAPK1
  - MAPK8
  - AXL
  - ARF1
  - MAPK3
  - MAPK9
  - MAPK10
  - EGFR
  - MAPK12
  - AKT3
  - SRC
  - MAPK11
  - MAPK13
  - AKT1
  - MAPK14
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AXL
  symbol: AXL
  source: hgnc_symbol
  hgnc_symbol: AXL
  entrez: '558'
- word: ARF1
  symbol: ARF1
  source: hgnc_symbol
  hgnc_symbol: ARF1
  entrez: '375'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4846185__F7
redirect_from: /figures/PMC4846185__F7
figtype: Figure
---
